Delivery Order SPE2DB22D2206-SPE2DB25FKE11
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Imatinib Mesylate 400 mg tablets in quantities of 30 units at a firm fixed price of $1,252.05. This order, which represents a non-competitive set-aside contract, is due for completion by July 21, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this delivery through its...
- The Defense Logistics Agency awarded a $1,194 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 400mg Imatinib Mesylate tablets. Under this order, Amerisourcebergen will deliver 30 tablets of the generic cancer drug to an address in Conshohocken, Pennsylvania by June 21, 2023. As a major supplier of pharmaceuticals to the Department of Defense, Amerisourcebergen likely supports DLA's mission to provide medical supplies and equipment to military treatment facilities...
- The Defense Logistics Agency awarded a $242,070 firm fixed price delivery order to AmerisourceBergen Drug Corporation for 30 boxes of 400mg Imatinib Mesylate tablets. The place of performance is AmerisourceBergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 20-21, 2023. This delivery order was issued against an existing DLA pharmaceutical supply vehicle to fulfill requirements for oncology medications in support of DOD health programs. No set aside...
- The Defense Logistics Agency awarded a $645.52 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 tablets of 400mg Imatinib Mesylate to be delivered to its Conshohocken, Pennsylvania facility by July 21, 2023. As a major pharmaceutical distributor, Amerisourcebergen will fulfill this order from the Defense Logistics Agency, which manages the Department of Defense's global supply chain, to supply this cancer treatment drug in support of DOD health programs. No set...
- The Defense Logistics Agency Troop Support Medical awarded a $248,440 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg tablets of imatinib mesylate. Under the contract, Amerisourcebergen will deliver 90 tablets to a location in Conshohocken, Pennsylvania by September 19, 2023. The Defense Logistics Agency manages the Department of Defense's global supply chain and is responsible for procuring pharmaceuticals and medical supplies to support military treatment...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The $2,233.75 firm fixed price delivery order is for the supply of 4,563,970,506 units of Imatinib Mesylate 400 mg tablets. The award has a period of performance through March 15, 2024 and does not have a set-aside designation. This delivery order is issued under an Indefinite Delivery Contract...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,139,158 units of Imatinib Mesylate 400 mg tablets in 30-count packages, with a ceiling value of $1,179.42. The contract is a firm-fixed-price, non-set-aside contract type with a performance period through May 6, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with...
- Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a $4,433.72 firm fixed price delivery order contract by the Defense Logistics Agency Troop Support Medical to supply 400mg Imatinib Mesylate tablets. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The contract period of performance spans October 21 to October 22, 2021. No subcontractors or set aside designations were identified. This delivery order was issued against an...
- The Defense Logistics Agency Troop Support Medical awarded a $113,330 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 tablets of 400mg Imatinib Mesylate to be delivered to their Conshohocken, Pennsylvania facility by August 21, 2023. Amerisourcebergen will provide the requested pharmaceutical product to the Defense Logistics Agency under this contract with performance at their corporate headquarters. No subcontractors or set aside designations were identified. The...
- The Defense Logistics Agency awarded a $645.52 delivery order to Amerisourcebergen Drug Corp Corporate Office Division to supply 30 tablets of 400mg Imatinib Mesylate. The prime contractor will deliver the pharmaceutical product to a location in Conshohocken, Pennsylvania under a firm fixed price contract running from August 14-15, 2023. No major subcontractors or set aside designations were identified. The Defense Logistics Agency manages the global supply chain for the U.S. military and...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FKE11Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Imatinib Mesylate 100 mg tablets (90-count) valued at $2,040.86 under a firm fixed-price contract. This award, issued on September 29, 2025, represents a competitive procurement with no set-aside designation and is scheduled for completion by September 30, 2025. The pharmaceutical product will be delivered to the prime contractor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major distributor of pharmaceutical and healthcare solutions to federal medical systems. This delivery order is issued under AmerisourceBergen's significant Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive prime vendor contract enables the company to supply a broad range of pharmaceutical products, medical supplies, and specialty medications to support military healthcare programs globally, including services to the Defense Health Agency and other government healthcare systems. The Imatinib Mesylate procurement fulfills critical pharmaceutical needs within the Defense Health Agency's medical supply chain, leveraging AmerisourceBergen's established capability to meet federal medical procurement requirements through competitive contracting.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 9/29/25 |